Research
The major focus of our research is the relationship between mutations
and human cancer. We wish to identify the sources of spontaneous
mutations in normal cells and whether there is an exponential increase
in mutations during the growth of human cancers. Do cancer cells
display a mutator phenotype and is this phenotype the basis for the
progressive ability of tumors to divide where they ought not, to invade
and to metastasize? Our current research efforts are in:
Fidelity
of DNA Replication: We are
continuing to measure the mechanism(s) by which DNA polymerases can
copy DNA with phenomenally high accuracy, approaching one error in
every 10^7 nucleotides polymerized. Our approach is to copy
biologically active DNA in vitro and then analyze the frequency and
types of mutations generated after transfection of the copied DNA into
cells. An analysis of mutations produced by polymerases is key to
evaluating the contribution of errors in DNA replication to spontaneous
mutations. Our goal is to reconstruct a human DNA replication system
that accurately copies DNA, and then ask whether and how this system is
defective in cancer cells.
HIV
Reverse Transcriptase: We have
extended the study on DNA polymerization to the reverse transcriptase
in the AIDS virus and to yeast. The exceptionally high error rate of
HIV reverse transcriptase in copying both RNA and DNA templates
suggests that this enzyme is responsible for the hypervariability of
the AIDS virus and provides a basis for the design of antiviral
nucleosides. The mutant DNA polymerases in yeast provide a tractable
eucaryotic system to categorize the function of different DNA
polymerases in cellular metabolism.
Oxygen
Free Radicals: An important
source of DNA damage is oxygen free radicals generated in cells by
normal metabolic processes. We have designed genetic assays to measure
the types of mutations caused by these reactive molecules. We have
evidence for unique mutations produced by oxygen free radicals, and
these could serve as fingerprints to assess the contribution of oxygen
radicals to spontaneous mutations and to mutations in cancers.
Applied
Molecular Evolution: We
have developed methods to construct vast populations of
oligonucleotides containing random sequences and insert them into
plasmids. After transfecting these plasmids into bacteria, we have used
genetic selection to obtain new active sequences that code for
promoters and enzymes that are not present in nature. These experiments
are based on the theoretical concept that among random sequences of
amino acids there are rare species that can code for active and
interesting molecules. We have obtained more than 3000 new herpes
simplex virus thymidine kinase mutants as candidate enzymes for gene
therapy in cancer. Other, ongoing studies using this technology,
include DNA polymerase, reverse transcriptase and enzymes involved in
DNA repair.
Selected
Publications
Anderson JP, Angerer B, Loeb LA (2005) Incorporation of reporter-labeled nucleotides by DNA polymerases. Biotechniques 38: 257-264.
Beckman RA, Loeb LA (2005) Genetic instability in cancer: theory and experiment. Semin Cancer Biol 15: 423-435.
Bielas JH, Loeb LA (2005) Mutator phenotype in cancer: timing and perspectives. Environ Mol Mutagen 45: 206-213.
Bielas JH, Loeb LA (2005) Quantification of random genomic mutations. Nat Methods 2: 285-290.
Camps M, Loeb LA (2005) Critical role of R-loops in processing replication blocks. Front Biosci 10: 689-698.
Loh E, Loeb LA (2005) Mutability of DNA polymerase I: Implications for the creation of mutant DNA polymerases. DNA Repair (Amst) 4: 1390-1398.
Anderson JP, Daifuku R, Loeb LA (2004) Viral error catastrophe by mutagenic nucleosides. Annu Rev Microbiol 58: 183-205.
Blank A, Bobola MS, Gold B, Varadarajan S, D DK, Meade EH, Rabinovitch PS, Loeb LA, Silber JR (2004) The Werner syndrome protein confers resistance to the DNA lesions N3-methyladenine and O6-methylguanine: implications for WRN function. DNA Repair (Amst) 3: 629-638.
Guo HH, Choe J, Loeb LA (2004) Protein tolerance to random amino acid change. Proc Natl Acad Sci U S A 101: 9205-9210.
Kamath-Loeb AS, Welcsh P, Waite M, Adman ET, Loeb LA (2004) The enzymatic activities of the Werner syndrome protein are disabled by the amino acid polymorphism R834C. J Biol Chem 279: 55499-55505.
Khateb S, Weisman-Shomer P, Hershco I, Loeb LA, Fry M (2004) Destabilization of tetraplex structures of the fragile X repeat sequence (CGG)n is mediated by homolog-conserved domains in three members of the hnRNP family. Nucleic Acids Res 32: 4145-4154.
Martin GM, Loeb LA (2004) Ageing: mice and mitochondria. Nature 429: 357-359.
Sneeden JL, Loeb LA (2004) Mutations in the R2 subunit of ribonucleotide reductase that confer resistance to hydroxyurea. J Biol Chem 279: 40723-40728.
Camps M, Naukkarinen J, Johnson BP, Loeb LA (2003) Targeted gene evolution in Escherichia coli using a highly error-prone DNA polymerase I. Proc Natl Acad Sci U S A 100: 9727-9732.
Davidson JF, Fox R, Harris DD, Lyons-Abbott S, Loeb LA (2003) Insertion of the T3 DNA polymerase thioredoxin binding domain enhances the processivity and fidelity of Taq DNA polymerase. Nucleic Acids Res 31: 4702-4709.
Shen JC, Lao Y, Kamath-Loeb A, Wold MS, Loeb LA (2003) The N-terminal domain of the large subunit of human replication protein A binds to Werner syndrome protein and stimulates helicase activity. Mech Ageing Dev 124: 921-930.
Shen JC, Loeb LA (2003) Mutations in the alpha8 loop of human APE1 alter binding and cleavage of DNA containing an abasic site. J Biol Chem 278: 46994-47001.
|